UA113467C2 - Застосування підотимоду для лікування запального захворювання кишечнику - Google Patents
Застосування підотимоду для лікування запального захворювання кишечникуInfo
- Publication number
- UA113467C2 UA113467C2 UAA201508969A UAA201508969A UA113467C2 UA 113467 C2 UA113467 C2 UA 113467C2 UA A201508969 A UAA201508969 A UA A201508969A UA A201508969 A UAA201508969 A UA A201508969A UA 113467 C2 UA113467 C2 UA 113467C2
- Authority
- UA
- Ukraine
- Prior art keywords
- pidotimod
- inflammatory bowel
- bowel disease
- treat inflammatory
- acceptable salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Даний винахід направлений на застосування підотимоду або його фізіологічно прийнятної солі для лікування запального захворювання кишечнику. Для лікування за даним винаходом підотимод або його фізіологічно прийнятну сіль можуть вводити або перорально, або ректально.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/EP2013/057208 WO2014161595A1 (en) | 2013-04-05 | 2013-04-05 | Use of pidotimod to treat inflammatory bowel disease |
Publications (1)
Publication Number | Publication Date |
---|---|
UA113467C2 true UA113467C2 (uk) | 2017-01-25 |
Family
ID=48048059
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201508969A UA113467C2 (uk) | 2013-04-05 | 2013-04-05 | Застосування підотимоду для лікування запального захворювання кишечнику |
Country Status (18)
Country | Link |
---|---|
US (1) | US20160058739A1 (uk) |
EP (1) | EP2981289A1 (uk) |
JP (1) | JP6122208B2 (uk) |
KR (1) | KR20150144743A (uk) |
CN (1) | CN105209072A (uk) |
AU (1) | AU2013385170A1 (uk) |
BR (1) | BR112015025296A2 (uk) |
CA (1) | CA2901338A1 (uk) |
EA (1) | EA201591930A1 (uk) |
HK (1) | HK1216150A1 (uk) |
MA (1) | MA38455B1 (uk) |
MX (1) | MX2015014061A (uk) |
NI (1) | NI201500147A (uk) |
PH (1) | PH12015502305A1 (uk) |
SG (1) | SG11201506509TA (uk) |
TN (1) | TN2015000433A1 (uk) |
UA (1) | UA113467C2 (uk) |
WO (1) | WO2014161595A1 (uk) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1231723B (it) | 1989-08-11 | 1991-12-21 | Poli Ind Chimica Spa | Derivati dell'acido piroglutammico, loro preparazioni e composizioni farmaceutiche che li contengono |
GB9412394D0 (en) * | 1994-06-21 | 1994-08-10 | Danbiosyst Uk | Colonic drug delivery composition |
US6946465B2 (en) * | 1999-02-02 | 2005-09-20 | 4 Aza Bioscience Nv | Immunosuppressive effects of pteridine derivatives |
US20070032477A1 (en) * | 2003-10-17 | 2007-02-08 | Waer Mark J A | Pteridine derivatives useful for making pharmaceutical compositions |
WO2005039587A1 (en) * | 2003-10-17 | 2005-05-06 | 4 Aza Bioscience Nv | Heterocycle-substituted pteridine derivatives and their use in therapy |
CN101134034A (zh) * | 2006-08-29 | 2008-03-05 | 江卫世 | 免疫促进药及其制备方法 |
US20090142769A1 (en) * | 2007-11-29 | 2009-06-04 | New York Society For The Ruptured And Crippled Maintaining The Hospital For Special Surgery | Methods for determining anti-TNF therapeutic response |
CN101623499A (zh) * | 2008-07-07 | 2010-01-13 | 杨喜鸿 | 抗生素和匹多莫德的药物组合物及其制备方法和药物应用 |
JP5647998B2 (ja) * | 2009-03-13 | 2015-01-07 | カトリーケ ユニバーシテイト ルーヴェン、ケー.ユー. ルーヴェン アール アンド ディー | 免疫抑制剤としてのチアゾロピリミジン調節因子 |
CN102234313B (zh) * | 2011-08-16 | 2013-02-27 | 青岛康地恩药业股份有限公司 | 一种匹多莫德的合成方法 |
CN102525903B (zh) * | 2012-01-20 | 2014-07-30 | 江苏吴中医药集团有限公司 | 一种匹多莫德的口服液体制剂 |
-
2013
- 2013-04-05 EA EA201591930A patent/EA201591930A1/ru unknown
- 2013-04-05 BR BR112015025296A patent/BR112015025296A2/pt active Search and Examination
- 2013-04-05 AU AU2013385170A patent/AU2013385170A1/en not_active Abandoned
- 2013-04-05 SG SG11201506509TA patent/SG11201506509TA/en unknown
- 2013-04-05 KR KR1020157025045A patent/KR20150144743A/ko not_active Application Discontinuation
- 2013-04-05 EP EP13714307.9A patent/EP2981289A1/en not_active Withdrawn
- 2013-04-05 CN CN201380074467.4A patent/CN105209072A/zh active Pending
- 2013-04-05 WO PCT/EP2013/057208 patent/WO2014161595A1/en active Application Filing
- 2013-04-05 UA UAA201508969A patent/UA113467C2/uk unknown
- 2013-04-05 CA CA2901338A patent/CA2901338A1/en not_active Abandoned
- 2013-04-05 MA MA38455A patent/MA38455B1/fr unknown
- 2013-04-05 MX MX2015014061A patent/MX2015014061A/es unknown
- 2013-04-05 JP JP2016505713A patent/JP6122208B2/ja active Active
- 2013-04-05 US US14/781,796 patent/US20160058739A1/en not_active Abandoned
-
2015
- 2015-09-18 TN TN2015000433A patent/TN2015000433A1/en unknown
- 2015-10-02 NI NI201500147A patent/NI201500147A/es unknown
- 2015-10-05 PH PH12015502305A patent/PH12015502305A1/en unknown
-
2016
- 2016-04-13 HK HK16104186.8A patent/HK1216150A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
TN2015000433A1 (en) | 2017-01-03 |
JP6122208B2 (ja) | 2017-04-26 |
WO2014161595A1 (en) | 2014-10-09 |
CN105209072A (zh) | 2015-12-30 |
CA2901338A1 (en) | 2014-10-09 |
PH12015502305A1 (en) | 2016-02-15 |
BR112015025296A2 (pt) | 2017-07-18 |
MA38455B1 (fr) | 2018-05-31 |
US20160058739A1 (en) | 2016-03-03 |
AU2013385170A1 (en) | 2015-09-24 |
EP2981289A1 (en) | 2016-02-10 |
KR20150144743A (ko) | 2015-12-28 |
JP2016515591A (ja) | 2016-05-30 |
SG11201506509TA (en) | 2015-10-29 |
MA38455A1 (fr) | 2017-12-29 |
HK1216150A1 (zh) | 2016-10-21 |
EA201591930A1 (ru) | 2016-02-29 |
NI201500147A (es) | 2016-01-06 |
MX2015014061A (es) | 2016-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12018500041A1 (en) | Substituted aza compoounds as irak-4 inhibitors | |
IN2015DN01156A (uk) | ||
EA201591296A1 (ru) | Фталазиноны и изохинолиноны в качестве ингибиторов rock | |
MX2015010125A (es) | Derivados de piridazinona-amidas. | |
HK1220324A1 (zh) | 用於治療血管緊張素相關疾病的方法、化合物和組合物 | |
MA39710A (fr) | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin | |
EA201690513A1 (ru) | Комбинация ингибитора mek и ингибитора erk для применения в лечении гиперпролиферативных заболеваний | |
EA201491854A1 (ru) | Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств | |
EA201500851A1 (ru) | ЭСТРА-1,3,5(10),16-ТЕТРАЕН-3-КАРБОКСАМИДЫ ДЛЯ ИНГИБИРОВАНИЯ 17β-ГИДРОКСИСТЕРОИД-ДЕГИДРОГЕНАЗЫ (AKR1C3) | |
MX2016006975A (es) | Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias. | |
EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
MX2016015961A (es) | Composiciones farmacéuticas que comprenden ácido dihomo-gamma-linolénico (dgla) y uso de las mismas. | |
EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
MX2015007945A (es) | Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas. | |
MX2020006075A (es) | Composiciones farmaceuticas de bendamustina. | |
EA201992389A1 (ru) | Замещенные n-арилэтил-2-аминохинолин-4-карбоксамиды и их применение | |
CY1118633T1 (el) | Χρηση pidotimod για την θεραπευτικη αγωγη ατοπικης δερματιτιδας | |
PH12016502480A1 (en) | Compounds, pharmaceutical composition and their use in treating neurodegenerative diseases | |
PH12015502703A1 (en) | Pharmaceutical compositions | |
PH12015502305A1 (en) | Use of pidotimod to treat inflammatory bowel disease | |
EA201992386A1 (ru) | Замещенные n-арилэтил-2-арилхинолин-4-карбоксамиды и их применение | |
PH12015502304A1 (en) | Use of pidotimod to treat irritable bowel syndrome | |
WO2016083315A8 (en) | Use of ox1r antagonists for the treatment of inflammatory bowel diseases | |
MX2017005669A (es) | Derivados de hidroxido de bencilo, preparacion de los mismos y uso terapeutico de los mismos. | |
IN2013MU02732A (uk) |